A detailed history of Zurcher Kantonalbank (Zurich Cantonalbank) transactions in Eli Lilly & CO stock. As of the latest transaction made, Zurcher Kantonalbank (Zurich Cantonalbank) holds 509,199 shares of LLY stock, worth $389 Million. This represents 1.38% of its overall portfolio holdings.

Number of Shares
509,199
Previous 509,199 -0.0%
Holding current value
$389 Million
Previous $451 Million -0.0%
% of portfolio
1.38%
Previous 1.38%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024

BUY
$772.14 - $960.02 $3.92 Million - $4.88 Million
5,083 Added 1.01%
509,199 $451 Million
Q2 2024

Jul 29, 2024

BUY
$724.87 - $909.04 $9.8 Million - $12.3 Million
13,514 Added 2.75%
504,116 $456 Million
Q1 2024

Apr 25, 2024

SELL
$592.2 - $792.28 $18.7 Million - $25 Million
-31,548 Reduced 6.04%
490,602 $382 Million
Q4 2023

Jan 30, 2024

SELL
$525.19 - $619.13 $24.3 Million - $28.6 Million
-46,274 Reduced 8.14%
522,150 $304 Million
Q3 2023

Oct 25, 2023

SELL
$434.7 - $599.3 $602,494 - $830,629
-1,386 Reduced 0.24%
568,424 $305 Million
Q2 2023

Aug 07, 2023

BUY
$350.74 - $468.98 $22.8 Million - $30.5 Million
65,120 Added 12.9%
569,810 $267 Million
Q1 2023

May 08, 2023

BUY
$310.63 - $364.82 $35.1 Million - $41.2 Million
113,057 Added 28.87%
504,690 $173 Million
Q4 2022

Feb 01, 2023

BUY
$321.55 - $374.67 $36.7 Million - $42.8 Million
114,195 Added 41.16%
391,633 $143 Million
Q3 2022

Nov 09, 2022

BUY
$296.48 - $337.87 $5.23 Million - $5.96 Million
17,635 Added 6.79%
277,438 $89.7 Million
Q2 2022

Aug 09, 2022

BUY
$278.73 - $327.27 $599,548 - $703,957
2,151 Added 0.83%
259,803 $84.2 Million
Q1 2022

Apr 21, 2022

BUY
$234.69 - $291.66 $2.74 Million - $3.41 Million
11,695 Added 4.75%
257,652 $73.8 Million
Q4 2021

Feb 01, 2022

SELL
$224.85 - $279.04 $1.14 Million - $1.41 Million
-5,070 Reduced 2.02%
245,957 $67.9 Million
Q3 2021

Nov 15, 2021

SELL
$221.6 - $272.71 $2.81 Million - $3.45 Million
-12,659 Reduced 4.8%
251,027 $58 Million
Q2 2021

Jul 30, 2021

SELL
$180.55 - $233.54 $1.34 Million - $1.73 Million
-7,422 Reduced 2.74%
263,686 $60.5 Million
Q1 2021

May 03, 2021

SELL
$164.32 - $212.72 $847,233 - $1.1 Million
-5,156 Reduced 1.87%
271,108 $50.6 Million
Q4 2020

Jan 28, 2021

SELL
$130.46 - $172.63 $3.43 Million - $4.54 Million
-26,296 Reduced 8.69%
276,264 $46.6 Million
Q3 2020

Nov 06, 2020

BUY
$146.22 - $169.13 $5.12 Million - $5.92 Million
35,011 Added 13.09%
302,560 $44.8 Million
Q2 2020

Jul 28, 2020

SELL
$136.42 - $164.18 $8.36 Million - $10.1 Million
-61,304 Reduced 18.64%
267,549 $43.9 Million
Q1 2020

May 06, 2020

BUY
$119.05 - $147.35 $15.6 Million - $19.3 Million
131,156 Added 66.34%
328,853 $45.6 Million
Q4 2019

Jan 21, 2020

SELL
$106.92 - $132.43 $46,189 - $57,209
-432 Reduced 0.22%
197,697 $26 Million
Q3 2019

Oct 18, 2019

BUY
$106.79 - $116.16 $687,407 - $747,721
6,437 Added 3.36%
198,129 $22.2 Million
Q2 2019

Jul 30, 2019

SELL
$110.79 - $129.32 $1.19 Million - $1.39 Million
-10,764 Reduced 5.32%
191,692 $21.2 Million
Q1 2019

Apr 29, 2019

SELL
$111.31 - $131.02 $3.02 Million - $3.55 Million
-27,125 Reduced 11.82%
202,456 $26.3 Million
Q4 2018

Jan 25, 2019

BUY
$105.9 - $118.64 $601,194 - $673,519
5,677 Added 2.54%
229,581 $26.6 Million
Q3 2018

Nov 09, 2018

SELL
$85.86 - $107.31 $1.03 Million - $1.29 Million
-11,982 Reduced 5.08%
223,904 $24 Million
Q2 2018

Aug 06, 2018

BUY
$75.7 - $86.88 $861,768 - $989,041
11,384 Added 5.07%
235,886 $20.1 Million
Q1 2018

May 03, 2018

SELL
$74.21 - $87.6 $13.8 Million - $16.3 Million
-186,612 Reduced 45.39%
224,502 $17.4 Million
Q4 2017

Jan 31, 2018

BUY
$81.94 - $87.89 $6.12 Million - $6.57 Million
74,733 Added 22.22%
411,114 $34.7 Million
Q3 2017

Nov 08, 2017

BUY
$77.07 - $85.54 $25.9 Million - $28.8 Million
336,381
336,381 $28.8 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $727B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Zurcher Kantonalbank (Zurich Cantonalbank) Portfolio

Follow Zurcher Kantonalbank (Zurich Cantonalbank) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Zurcher Kantonalbank (Zurich Cantonalbank), based on Form 13F filings with the SEC.

News

Stay updated on Zurcher Kantonalbank (Zurich Cantonalbank) with notifications on news.